[go: up one dir, main page]

NO992062D0 - Preparat for behandling av astma, inneholdende loratadin og et dekongestionsmiddel - Google Patents

Preparat for behandling av astma, inneholdende loratadin og et dekongestionsmiddel

Info

Publication number
NO992062D0
NO992062D0 NO992062A NO992062A NO992062D0 NO 992062 D0 NO992062 D0 NO 992062D0 NO 992062 A NO992062 A NO 992062A NO 992062 A NO992062 A NO 992062A NO 992062 D0 NO992062 D0 NO 992062D0
Authority
NO
Norway
Prior art keywords
decongestant
asthma
preparation
treatment
containing loratadine
Prior art date
Application number
NO992062A
Other languages
English (en)
Norwegian (no)
Other versions
NO992062L (no
Inventor
Alan G Harris
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of NO992062L publication Critical patent/NO992062L/no
Publication of NO992062D0 publication Critical patent/NO992062D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO992062A 1996-10-31 1999-04-29 Preparat for behandling av astma, inneholdende loratadin og et dekongestionsmiddel NO992062D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US73966996A 1996-10-31 1996-10-31
PCT/US1997/019158 WO1998018470A1 (en) 1996-10-31 1997-10-29 Composition, for the treatment of asthma, containing loratadine and a decongestant

Publications (2)

Publication Number Publication Date
NO992062L NO992062L (no) 1999-04-29
NO992062D0 true NO992062D0 (no) 1999-04-29

Family

ID=24973307

Family Applications (1)

Application Number Title Priority Date Filing Date
NO992062A NO992062D0 (no) 1996-10-31 1999-04-29 Preparat for behandling av astma, inneholdende loratadin og et dekongestionsmiddel

Country Status (21)

Country Link
EP (1) EP0941091A1 (es)
JP (1) JP2000505104A (es)
KR (1) KR20000052922A (es)
CN (1) CN1235545A (es)
AR (1) AR008908A1 (es)
AU (1) AU731756B2 (es)
BR (1) BR9712705A (es)
CA (1) CA2268546A1 (es)
CO (1) CO4910128A1 (es)
CZ (1) CZ150999A3 (es)
HU (1) HUP9904075A3 (es)
ID (1) ID23431A (es)
IL (1) IL129662A0 (es)
NO (1) NO992062D0 (es)
NZ (1) NZ335078A (es)
PE (1) PE11399A1 (es)
PL (1) PL333056A1 (es)
SK (1) SK54599A3 (es)
TR (1) TR199901003T2 (es)
WO (1) WO1998018470A1 (es)
ZA (1) ZA979731B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1205799A (en) * 1997-10-29 1999-05-17 J-Med Pharmaceuticals, Inc. Antihistamine/decongestant regimens for treating rhinitis
US6132758A (en) * 1998-06-01 2000-10-17 Schering Corporation Stabilized antihistamine syrup
IT1303671B1 (it) * 1998-07-28 2001-02-23 Nicox Sa Sali dell'acido nitrico con farmaci attivi nel trattamento dipatologie del sistema respiratorio
WO2000015226A1 (en) * 1998-09-10 2000-03-23 Schering Corporation Antihistamines for treating non-infective sinusitis or otitis media
US6521254B2 (en) 1998-12-07 2003-02-18 J-Med Pharmaceuticals, Inc. Single-dose antihistamine/decongestant formulations for treating rhinitis
EP1154762B1 (en) * 1999-02-23 2003-11-05 Yuhan Corporation Pharmaceutical capsule compositions containing loratadine and pseudoephedrine
KR100505899B1 (ko) * 1999-02-23 2005-08-01 주식회사유한양행 로라타딘과 슈도에페드린을 함유한 캅셀제 조성물
AU3924500A (en) * 1999-03-29 2000-10-16 Schering Corporation Methods and compositions for treating allergic and related disorders using fluorinated descarboethoxyloratadine
SK287105B6 (sk) * 1999-12-20 2009-12-07 Schering Corporation Dvojvrstvový orálny dávkový prostriedok s predĺženým uvoľňovaním
SK287684B6 (sk) * 1999-12-20 2011-06-06 Schering Corporation Pevná orálna farmaceutická dávková forma s predĺženým uvoľňovaním
CA2405238C (en) * 2000-04-14 2014-03-18 J-Med Pharmaceuticals, Inc. Single-dose antihistamine/decongestant formulations for treating rhinitis
WO2001089527A2 (en) * 2000-05-24 2001-11-29 Schering Corporation Pharmaceutical composition comprising loratadine and a nasal decongestant
HUP0401630A2 (hu) * 2001-06-20 2004-12-28 Schering Corp. Antihisztaminok alkalmazása nazális vérbőség és orrdugulás kezelésére szolgáló gyógyszerkészítmény előállítására
RU2423979C2 (ru) * 2005-06-17 2011-07-20 АФТ Фармасьютикалз Лимитед Новая фармацевтическая композиция и ее применение в способе лечения пациентов с гиперемией и отеком слизистой оболочки верхних дыхательных путей
CA2612179C (en) 2005-06-17 2016-08-02 Aft Pharmaceuticals Limited A pharmaceutical composition comprising loratadine and its use to treat patients with upper respiratory mucosal congestion
CL2007001584A1 (es) * 2006-06-01 2008-01-25 Msd Consumer Care Inc Composicion farmaceutica que comprende: un nucleo con fenilefrina en forma de liberacion inmediata y una capa erosionable que comprende fenilefrina y una matriz de liberacion sostenida; util para tratar los sintomas del resfriado, influenza, alergias o rinitis no alergicas.
NZ573174A (en) * 2006-06-01 2012-01-12 Msd Consumer Care Inc Sustained release pharmaceutical dosage form containing phenylephrine
KR101540191B1 (ko) * 2014-02-24 2015-07-28 성균관대학교산학협력단 로라타딘을 포함하는 항염증용 조성물

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1110397A (en) * 1964-10-02 1968-04-18 Mead Johnson & Co Ephedrine composition
US4990535A (en) * 1989-05-03 1991-02-05 Schering Corporation Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine
US5407686A (en) * 1991-11-27 1995-04-18 Sidmak Laboratories, Inc. Sustained release composition for oral administration of active ingredient
US5314697A (en) * 1992-10-23 1994-05-24 Schering Corporation Stable extended release oral dosage composition comprising loratadine and pseudoephedrine
US5595997A (en) * 1994-12-30 1997-01-21 Sepracor Inc. Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine

Also Published As

Publication number Publication date
NO992062L (no) 1999-04-29
CZ150999A3 (cs) 1999-10-13
HUP9904075A2 (hu) 2000-05-28
NZ335078A (en) 2000-10-27
AR008908A1 (es) 2000-02-23
PL333056A1 (en) 1999-11-08
CA2268546A1 (en) 1998-05-07
ID23431A (id) 2000-04-20
KR20000052922A (ko) 2000-08-25
AU4995397A (en) 1998-05-22
AU731756B2 (en) 2001-04-05
ZA979731B (en) 1998-04-29
IL129662A0 (en) 2000-02-29
CO4910128A1 (es) 2000-04-24
CN1235545A (zh) 1999-11-17
JP2000505104A (ja) 2000-04-25
PE11399A1 (es) 1999-02-09
SK54599A3 (en) 2000-08-14
TR199901003T2 (xx) 1999-07-21
HUP9904075A3 (en) 2002-02-28
WO1998018470A1 (en) 1998-05-07
BR9712705A (pt) 1999-10-26
EP0941091A1 (en) 1999-09-15

Similar Documents

Publication Publication Date Title
NO992062D0 (no) Preparat for behandling av astma, inneholdende loratadin og et dekongestionsmiddel
IS1981B (is) Nýtt form S-handhverfu ómeprasóls og lyfjablöndursem innihalda það
NO924768D0 (no) Farmasoeytisk preparat og fremgangsmaate for dets fremstilling
NO307707B1 (no) Spiroazabicykliske forbindelser, farmasøytisk preparat inneholdende slike forbindelser og anvendelse derav
NO960837D0 (no) Nye kuler for regulert frigjöring og et farmasöytisk preparat inneholdende slike
NO20000932D0 (no) Farmasøytisk preparat for kombinasjon av piperidinoalkanol og dekongestant
FI950444L (fi) Lääkkeen inhalointilaite ja -menetelmä
DE69513735D1 (de) Benutzerprogrammierbares Unterhaltungsgerät und- Verfahren
NO911020D0 (no) Fremgangsmaate og preparat for koiontoforese.
NO20002846D0 (no) Inhaleringsanordning og fremgangsmÕte ved samme
IS4509A (is) Innúðatæki, aðferð við að dreifa lyfjafræðilega virku efni og aðferð við inngjöf á skammti af lyfjafræðilega virku efni
NO991815L (no) Oksadiazoler, fremgangsmÕter for deres fremstilling og deres anvendelse som medikamenter
NO965343L (no) For inneholdende naturlegemiddel
ITRM920412A0 (it) Eteroprostanoidi, procedimento per la loro preparazione e loro impiegoterapeutico.
NO964306D0 (no) Ligninblanding, fremstilling og anvendelse derav
NO932915D0 (no) Mikroporoest krystallinsk silikoaluminofosfat og fremgangsmaate for fremstilling av dette
NO951447D0 (no) Organoaluminoksyprodukt, fremstilling og anvendelse
NO2005007I1 (no) Pemetrexed og farmasoytisk akseptable salter derav
DK0776363T3 (da) Ribozymbibliotek, fremstilling og anvendelse heraf
NO880434D0 (no) Anestetisk preparat og fremgangsmaate for bruk derav.
NO922480D0 (no) Krystallinsk, zeolitanalogt gallosilikat og fremgangsmaatefor fremstilling av dette
NO20015806D0 (no) Farmasöytisk preparat inneholdende et tetrahydrobenz[c,d]indol-6-karboksamid og anvendelse derav
CZ2000522A3 (cs) Farmaceutický prostředek na bázi piperidinalkanolového antihistaminika a použití
NO922998L (no) Perforert drivkrutt, anordning for dets fremstilling og anvendelse av anordningen
NO924290L (no) Azabenzimidazoler for behandling av astma, artritt og lignende lidelser

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application